Skip to main content
OpenTrials

Clinical trial condition

Plasma Cell Myeloma

Explore clinical trials studying Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

80 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Plasma Cell Myeloma trial results

Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

NCT04566328

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 647 locations
View Trial Details
Recruiting

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

NCT05561387

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 397 locations
View Trial Details
Recruiting

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

NCT03858205

Conditions
Blood Protein Disorders, Bone Pain, Cardiovascular Diseases, +15 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View Trial Details
Enrolling by invitation

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

NCT05669989

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Washington University- Site Number : 8400001 St Louis, Missouri, United States
  • Investigational Site Number : 0360006 Blacktown, New South Wales, Australia
  • Investigational Site Number : 0360001 Saint Leonards, New South Wales, Australia
  • Investigational Site Number : 0360003 Wollongong, New South Wales, Australia
View all 37 locations
View Trial Details

Related conditions